Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Press Releases and Statements Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low According to NIDA Survey Dec 18, 2024 Pediatric Cough/Cold Dosing Press Releases and Statements CHPA Joins U.S. Senators Grassley & Coons at Anti-Counterfeiting Event Dec 13, 2024